In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy
暂无分享,去创建一个
John A. Detre | Arijitt Borthakur | Ravinder Reddy | Mohammad Haris | Hari Hariharan | Sanjana Reddy | Rachelle Crescenzi | Catherine Debrosse | Ravi Prakash Nanga | Michiyo Iba | Virginia M. Y. Lee | J. Detre | A. Borthakur | R. Reddy | M. Haris | R. Nanga | H. Hariharan | M. Iba | R. Crescenzi | Sanjana Reddy | C. Debrosse
[1] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[2] J. Trojanowski,et al. Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy , 2010, The Journal of Neuroscience.
[3] John Q Trojanowski,et al. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. , 2010, The American journal of pathology.
[4] Lin Xie,et al. Increased hippocampal neurogenesis in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Trojanowski,et al. Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.
[6] R. Bartha,et al. Reduced hippocampal glutamate in Alzheimer disease , 2011, Neurobiology of Aging.
[7] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[8] Greenamyre Jt,et al. Neurotransmitter receptors in Alzheimer disease. , 1993 .
[9] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[10] J. Glennon,et al. Age‐related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild‐type mice , 2008, Journal of neurochemistry.
[11] Lin Xie,et al. Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Trojanowski,et al. The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice , 2012, The Journal of Neuroscience.
[13] B. Ross,et al. Reversal of Metabolic Deficits by Lipoic Acid in a Triple Transgenic Mouse Model of Alzheimer's Disease: A 13C NMR Study , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] I. Grundke‐Iqbal,et al. Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Rae,et al. Glutamate Metabolism is Impaired in Transgenic Mice with Tau Hyperphosphorylation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[17] K. Kosik,et al. Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains , 2009, FEBS letters.
[18] Carol D. Hicks,et al. Author ' s personal copy Volumetric MRI and MRS provide sensitive measures of Alzheimer ' s disease neuropathology in inducible Tau transgenic mice ( rTg 4510 ) , 2011 .
[19] I. Grundke‐Iqbal,et al. Enhancement of dentate gyrus neurogenesis, dendritic and synaptic plasticity and memory by a neurotrophic peptide , 2011, Neurobiology of Aging.
[20] L. Mosconi,et al. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[21] Ravinder Reddy,et al. Imaging of glutamate neurotransmitter alterations in Alzheimer's disease , 2013, NMR in biomedicine.
[22] Ronald J Killiany,et al. Hippocampal Subregions are Differentially Affected in the Progression to Alzheimer's Disease , 2012, Anatomical record.
[23] P. Sah,et al. Properties of Doublecortin Expressing Neurons in the Adult Mouse Dentate Gyrus , 2012, PloS one.
[24] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[25] John A. Detre,et al. Magnetic Resonance Imaging of Glutamate , 2011, Nature Medicine.
[26] G. Allan Johnson,et al. High-throughput morphologic phenotyping of the mouse brain with magnetic resonance histology , 2007, NeuroImage.
[27] E. Vanmechelen,et al. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.
[28] S. Augood,et al. Frontal Lobe Dysfunction in Progressive Supranuclear Palsy , 2000, Journal of neurochemistry.
[29] F. Gage,et al. Neurogenesis in the adult human hippocampus , 1998, Nature Medicine.